ATE494377T1 - Vakzine gegen ipnv die aus hefezellen isoliert werden - Google Patents

Vakzine gegen ipnv die aus hefezellen isoliert werden

Info

Publication number
ATE494377T1
ATE494377T1 AT01980767T AT01980767T ATE494377T1 AT E494377 T1 ATE494377 T1 AT E494377T1 AT 01980767 T AT01980767 T AT 01980767T AT 01980767 T AT01980767 T AT 01980767T AT E494377 T1 ATE494377 T1 AT E494377T1
Authority
AT
Austria
Prior art keywords
vaccines
ipnv
isolated
vaccine
polypeptide
Prior art date
Application number
AT01980767T
Other languages
English (en)
Inventor
William Melvin
Suzanne Breeman
Marie Labus
Original Assignee
Univ Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0027644A external-priority patent/GB0027644D0/en
Priority claimed from GB0030765A external-priority patent/GB0030765D0/en
Application filed by Univ Aberdeen filed Critical Univ Aberdeen
Application granted granted Critical
Publication of ATE494377T1 publication Critical patent/ATE494377T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT01980767T 2000-11-11 2001-11-12 Vakzine gegen ipnv die aus hefezellen isoliert werden ATE494377T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0027644A GB0027644D0 (en) 2000-11-11 2000-11-11 Fish vaccine
GB0030765A GB0030765D0 (en) 2000-12-14 2000-12-14 Fish vaccine
PCT/GB2001/004986 WO2002038770A1 (en) 2000-11-11 2001-11-12 Yeast derived vaccine against ipnv

Publications (1)

Publication Number Publication Date
ATE494377T1 true ATE494377T1 (de) 2011-01-15

Family

ID=26245278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01980767T ATE494377T1 (de) 2000-11-11 2001-11-12 Vakzine gegen ipnv die aus hefezellen isoliert werden

Country Status (8)

Country Link
EP (1) EP1334197B1 (de)
AT (1) ATE494377T1 (de)
AU (1) AU2002212555A1 (de)
CA (1) CA2428027C (de)
DE (1) DE60143810D1 (de)
DK (1) DK1334197T3 (de)
NO (1) NO333007B1 (de)
WO (1) WO2002038770A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1541036A1 (de) * 2001-03-23 2005-06-15 Advanced Bionutrition Corporation Futtermittel für Vieh- und Fischzuccht enthaltend Meeresalgen
US7317142B2 (en) 2002-12-13 2008-01-08 Prodi Gene, Inc. Immunization of fish with plant-expressed recombinant proteins
US7754223B2 (en) 2003-10-07 2010-07-13 Eurogentec Sa Piscirickettsia salmonis antigens and use thereof
WO2006037383A1 (en) * 2004-10-01 2006-04-13 Michel Thiry Piscirickettsia salmonis antigens and use thereof
US8221767B2 (en) 2006-12-20 2012-07-17 Advanced Bionutrition Corporation Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast
CA2687208C (en) * 2006-12-22 2017-02-14 Soluciones Biotecnologicas Innovacion Ltda Process and formulation for immunizing fish in aquaculture systems
CA2708167C (en) 2007-12-19 2016-11-29 David Francis Kirke Vaccine antigens from piscirickettsia salmonis
CN104884084B (zh) 2012-09-26 2018-05-22 Fvg有限公司 鱼用亚单位浸泡疫苗
JP7186401B2 (ja) * 2017-02-28 2022-12-09 フエー・イー・ベー・フエー・ゼツト・ウエー タンパク質の経口送達のための手段及び方法
CN115804837B (zh) * 2022-02-24 2023-06-20 中国水产科学研究院黑龙江水产研究所 一种传染性胰脏坏死病佐剂疫苗及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165925A (en) * 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus

Also Published As

Publication number Publication date
WO2002038770A1 (en) 2002-05-16
CA2428027C (en) 2012-09-11
NO20032097L (no) 2003-07-10
EP1334197B1 (de) 2011-01-05
EP1334197A1 (de) 2003-08-13
CA2428027A1 (en) 2002-05-16
NO20032097D0 (no) 2003-05-09
NO333007B1 (no) 2013-02-18
DK1334197T3 (da) 2011-04-04
DE60143810D1 (de) 2011-02-17
AU2002212555A1 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
Yusibov et al. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1
Kofler et al. Mimicking live flavivirus immunization with a noninfectious RNA vaccine
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
EA200801221A1 (ru) Вирусные вакцины, полученные из клеток, с низкими уровнями остаточной клеточной днк
WO2004098533A3 (en) Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
SI1685243T1 (sl) Imortalizirane ptičje celične linije za produkcijo virusov
NZ589755A (en) Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same
WO2007095320A3 (en) Hpv antigens, vaccine compositions, and related methods
WO2006095330A3 (en) Methods and immunogenic cell preparations for treating antigen-associated diseases
WO2005035558A3 (en) Piscirickettsia salmonis antigens and use thereof
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
MXPA05005202A (es) Vacuna.
DE60229659D1 (de) Antigen-raster enthaltend rankl zur behandlung von knochenerkrankungen
ATE354370T1 (de) Inaktivierte immunogene bakterielle ganzzell- zusammensetzungen
AU2003288510A1 (en) Immunizing fish against viral infection
WO2005115448A8 (en) Multi plasmid system for the production of influenza virus
WO2008027560A3 (en) Holin-enhanced vaccines and reagents, and methods of use thereof
EE200200157A (et) Vaktsiin
WO2005012538A3 (en) Accelerated vaccination
TW200509964A (en) VP1 of foot-and-mouth disease virus
DK1423525T3 (da) Rekombinant MVA, der kan eksprimere HCV-strukturantigener
EP4410970A3 (de) Effizientes zellkultursystem für hepatitis-c-virus-genotyp 6a
GB2429711A (en) Heart and skeletal muscle inflammation (HSMI) virus
AR248047A1 (es) Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1.
AU5489500A (en) Isolation of a human retrovirus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties